Digital Pathology
Owkin Inks Deal to Offer Its Colorectal Cancer Test Through Proscia's Platform
The firms said that Owkin's MSIntuit CRC v2 screening test for microsatellite instability will be available through the Proscia Concentriq software platform.
Owkin, AstraZeneca Partner to Develop AI-Based Breast Cancer Prescreening Tool
The solution will use Owkin's data network and artificial intelligence to prescreen for gBRCA mutations in breast cancer directly from digital pathology slides.
Digital Pathology Firm Mindpeak Raises $15.3M in Series A Financing Round
The new funding will allow the company to further expand its commercialization in multiple countries.
Roche, Stratipath Ink Deal to Distribute Breast Cancer Digital Pathology Solution
Stratipath Breast risk stratifies breast cancer by analyzing digitized histopathology slides of breast cancer tissue.
Io9 AI-Driven Digital Pathology Test Shows Potential to Inform Breast, Ovarian Cancer Therapy
Premium
The firm hopes to develop its DeepHRD digital pathology test as an alternative to costly companion diagnostics based on next-generation sequencing.
Feb 29, 2024